101 Real-world analysis of the impact of pemetrexed in first-line maintenance (1LM) with immunotherapy (IO) for non-squamous (NSQ) advanced/metastatic non-small cell lung cancer (a/mNSCLC) lacking targetable mutations, prior to and during the COVID-19 pandemic - Gomes, Fabio; Gilding, Niall; Tan, Vivian; Christoforou, Katerina; Rule, Joanne; Aziez, Amine; Januszewski, Adam; Minchom, Anna (Lung Cancer (01695002), 2024)